Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Prostate Cancer

Breast Cancer

Gastrointestinal Cancer

Colorectal Cancer

Ovarian Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Prostate Cancer

FDA Grants Priority Review to Olaparib for HRR-Mutant mCRPC

The FDA has granted a priority review designation to a supplemental new drug application for olaparib (Lynparza) for the treatment of patients with metastatic castration-resistant prostate cancer who have deleterious or suspected deleterious or somatic...
Read More >>

FDA Approvals Boost Competition in Treatment Landscapes

FDA Grants Priority Review to Rucaparib for mCRPC

SITC Poised to Expand Toolkit of Immunotherapy Guidelines

CARD Trial Establishes Cabazitaxel as a Third-Line Standard in mCRPC

Novel Imaging Slated to Change Trajectory of Prostate Cancer Treatment

View More Stories >>

View Conference Coverage

2020 SGO Winter Meeting

2020 Gastrointestinal Cancers Symposium

2019 San Antonio Breast Cancer Symposium

2019 ASH Annual Meeting

2019 International Congress of the Society for Melanoma Research

Dr. Mohler on Need for Genetic Counselors for Early Detection of Prostate Cancer

Dr. Bryce on Next-Generation Radiopharmaceuticals in Prostate Cancer

Dr. Aoun on Imaging Modalities in Prostate Cancer

Dr. Chang on the Evolution of Surgical Techniques in Prostate Cancer

Dr. Heath on the Toxicity Profiles of Oral Antiandrogens in Nonmetastatic CRPC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Final Thoughts on Evolving Treatment of Prostate Cancer

Optimal Timing for Radium-223 With AR-Targeted Therapy

CARD: Sequencing Therapies in Metastatic Prostate Cancer

Role of Biomarkers in Metastatic Prostate Cancer

Prostate Cancer: Characterize Biologies, Integrate Therapies

OncLive houses thousands of videos that provide updates and information.
See more Videos

Metastatic CSPC: Toxicity Management & Future Treatment

The Role of Enzalutamide in Treating Metastatic CSPC

The Approval of Apalutamide for Metastatic CSPC

The STAMPEDE Trial Long Term Follow-Up Data

The Future of Nonmetastatic CRPC Management

The Impact of Recently Approved AR-Targeted Therapy

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Redefining Advanced Prostate Cancer with Novel Imaging

Raoul S. Concepcion, MD, FACS, moderates this discussion with Daniel George, MD; Alec Koo, MD; Phillip Koo, MD; and Neal Shore, MD, FACS. The group of urologists and oncologists specializing in prostate cancer discusses redefining advanced prostate cancer with novel imaging.
View Now

Metastatic Prostate Cancer Update

Charles Ryan, MD, describes his approach to use of androgen receptor-targeted therapy for the treatment of castration-resistant prostate cancer. Dr. Ryan provides additional perspective on the topic of predictive markers.
View Now

Featured Video

Dr. Esteva on the Future of Biosimilars in Breast Cancer

Francisco J. Esteva, MD, PhD, director, breast medical oncology program, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, discusses the future use of biosimilars in breast cancer within the United States. View now

FDA Approvals in Urothelial Cancer and GIST, Promising Data in Urothelial Carcinoma, and More